More articles from Supplement

You have access
Recent Advances in Radiotracers Targeting Novel Cancer-Specific Biomarkers in China: A Brief Overview
Jingming Zhang, Fei Kang, Xiao Wang, Xuejiao Chen, Xing Yang, Zhi Yang and Jing Wang

Journal of Nuclear Medicine May 1, 2024, 65 (Supplement 1) 38S-45S; DOI: https://doi.org/10.2967/jnumed.123.266314
You have access
Clinical Implementation of Total-Body PET in China
Yaping Wu, Tao Sun, Yee Ling Ng, Jianjun Liu, Xiaohua Zhu, Zhaoping Cheng, Baixuan Xu, Nan Meng, Yun Zhou and Meiyun Wang

Journal of Nuclear Medicine May 1, 2024, 65 (Supplement 1) 64S-71S; DOI: https://doi.org/10.2967/jnumed.123.266977
You have access
Landscape of Nuclear Medicine in China and Its Progress on Theranostics
Weidong Yang, Fei Kang, Yue Chen, Zhaohui Zhu, Feng Wang, Chunxia Qin, Jin Du, Xiaoli Lan and Jing Wang

Journal of Nuclear Medicine May 1, 2024, 65 (Supplement 1) 29S-37S; DOI: https://doi.org/10.2967/jnumed.123.266968
You have access
The Role of Total-Body PET in Drug Development and Evaluation: Status and Outlook
Xiangxi Meng, Xiangxing Kong, Lei Xia, Runze Wu, Hua Zhu and Zhi Yang

Journal of Nuclear Medicine May 1, 2024, 65 (Supplement 1) 46S-53S; DOI: https://doi.org/10.2967/jnumed.123.266978
You have access
Melanin-Targeting Radiotracers and Their Preclinical, Translational, and Clinical Status: From Past to Future
Xiao Zhang, Zhaoguo Lin, Yuan Feng, Fei Kang, Jing Wang and Xiaoli Lan

Journal of Nuclear Medicine May 1, 2024, 65 (Supplement 1) 19S-28S; DOI: https://doi.org/10.2967/jnumed.123.266945
You have access
Advancing Global Nuclear Medicine: The Role and Future Contributions of China
Haojun Chen, Kuangyu Shi, Weibo Cai, Sijin Li and Jing Wang

Journal of Nuclear Medicine May 1, 2024, 65 (Supplement 1) 1S-S3; DOI: https://doi.org/10.2967/jnumed.124.267918
You have access
Advantages and Challenges of Total-Body PET/CT at a Tertiary Cancer Center: Insights from Sun Yat-sen University Cancer Center
Wanqi Chen, Yinghe Li, Zhijian Li, Yongluo Jiang, Yingpu Cui, Jiling Zeng, Yiwen Mo, Si Tang, Shatong Li, Lei Liu, Yumo Zhao, Yingying Hu and Wei Fan

Journal of Nuclear Medicine May 1, 2024, 65 (Supplement 1) 54S-63S; DOI: https://doi.org/10.2967/jnumed.123.266948
You have access
Pathway to Approval of Innovative Radiopharmaceuticals in China
Shuxian An, Lu Wang, Fang Xie, Dawei Jiang, Gang Huang, Jianjun Liu, Xiaowei Ma and Weijun Wei

Journal of Nuclear Medicine May 1, 2024, 65 (Supplement 1) 72S-76S; DOI: https://doi.org/10.2967/jnumed.123.267127
You have access
Dosimetry for Radiopharmaceutical Therapy: The European Perspective
Michael Lassmann, Uta Eberlein, Jonathan Gear, Mark Konijnenberg and Jolanta Kunikowska

Journal of Nuclear Medicine December 1, 2021, 62 (Supplement 3) 73S-79S; DOI: https://doi.org/10.2967/jnumed.121.262754
You have access
Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine
Thomas Langbein, Wolfgang A. Weber and Matthias Eiber

Journal of Nuclear Medicine September 1, 2019, 60 (Supplement 2) 13S-19S; DOI: https://doi.org/10.2967/jnumed.118.220566

Main menu

User menu

Search

More articles from Supplement

Pages